跳至主要内容
临床试验/NCT04041089
NCT04041089已完成不适用

Development and Evaluation of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy (PCA)

Centre Hospitalier Universitaire de Nice2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2019年9月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3
试验地点
2
主要终点
Effectiveness evaluation

研究概览

简要总结

Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders.

The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >50 years old
  • Male or Female
  • Patients with a diagnosis of PCA according to the criteria of Tang-Wai et al (2004)
  • Voluntary, written and informed consent of the patient himself or its legal representative (guardian/curator), with oral consent of the patient in all cases
  • Anti-Alzheimer's and psychotropic treatments stable for one month, if taken by the patient
  • Affiliation to a social security system

排除标准

  • Uncorrected visual disorders with non-degenerative etiology (AV<0.5)
  • Person under the protection of justice
  • Pregnant women (a pregnancy test will be performed in premenopausal women)

结局指标

主要结局

Effectiveness evaluation

时间窗: At week 34

Effectiveness will be evaluated a score based on success rate (from 0 to 10), reaction time and eye-recording .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Development of the Effectiveness of Rehabilitation... | 临床试验